BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids derived from a naturally occurring protective protein found in human gastric juice. It has been extensively studied in preclinical models for its regenerative and cytoprotective properties.
Unlike many peptides that target the growth hormone axis, BPC-157 is primarily investigated for its ability to accelerate wound healing, protect and heal the gut lining, and support recovery from musculoskeletal injuries.
BPC-157 is not FDA-approved for medical use. It has primarily been studied in animal models, with limited human clinical data available. Today it is typically available only through research or compounding contexts and is commonly used off-label in peptide therapy clinics.
Clinical evidence supporting these uses in humans remains limited; most data comes from animal studies.
BPC-157 is believed to exert its effects through multiple pathways:
These mechanisms contribute to its broad regenerative profile across multiple tissue types.
This study demonstrated that BPC-157 accelerated tendon-to-bone healing in a rat model, suggesting potential for musculoskeletal recovery.
Researchers examined the cytoprotective effects of BPC-157 on gastric mucosa, confirming significant protective and healing activity.
This research showed BPC-157 promoted angiogenesis and accelerated wound healing through upregulation of growth factor pathways.
A comprehensive review of BPC-157's pharmacological effects across multiple organ systems, including musculoskeletal, gastrointestinal, and neurological tissues.
If you're using a browser with advanced ad blocking security measures, the above study links may not work. You can copy the link and paste it into a new window.
Disclaimer: The information on this page was generated with the assistance of artificial intelligence and compiled from publicly available sources. While efforts are made to ensure accuracy, information may be incomplete, outdated, or incorrect and should not be relied upon as medical advice.
R2 Medical Clinic uses medications sourced from compounding pharmacies. Compounded drugs have not been approved by the FDA; have not been reviewed by the FDA for safety, efficacy, or quality; and have not been demonstrated to the FDA to be safe or effective for their intended use. The processes by which the compounded drugs are manufactured have not been reviewed by the FDA. FDA approved products containing semaglutide and tirzepatide are available.